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Retention functions: A solution to whether a kidney is obstruct-
ed. K. E. Britton, C. C. Nimmon, H. N. Whitfield, I. Kelsey Fry,
W. F. Hendry, andJ. E. A. Wickham. St. Bartholomew's Hospi-
tal, London, England. The recognition that a radiologically di-
lated pelvis does not necessarily correspond to obstruction to the
outflow tract requiring surgical intervention has lead to alterna-
tive methods—antegrade pressure flow (APF) estimations by di-
rect puncture, urography with furosemide (UF), and use of ra-
dionuclides. Since previous methods of analysis of radionuclide
data have been unsatisfactory, we introduce the concept of pa-
renchymal and whole kidney retention functions (RF), which are
related to the frequency distribution of delay times in each kid-
ney, as a solution to this problem. A gamma camera linked to a
computer, a probe over the heart, and an i.v. injection of 15 mCi
of 99mTc DTPA are used. Regions of interest are selected for
each nonrenal environment, for each whole kidney, pelvis, and
parenchyme. Data from these and the aortic input curve yield by
deconvolution analysis separate total and parenchymal RF units.
With a dilated nonobstructed pelvis, parenchymal RF is normal
(< 70) and whole kidney RF is increased (> 80), whereas with a
dilated obstructed pelvis both RF units are increased. It is a
graded response. Increase in parenchymal RF units indicating
deterioration in function precedes reduction in uptake of radio-
nuclide in the unoperated obstructed kidney, and, conversely,
reduction in parenchymal RF precedes improvement in uptake.
Taking the results of the RF technique with those of APF and
UF and the clinical assessment, each was correct in 18/20(P < 0.01). This methodology is noninvasive, uses standard
apparatus, and has been accepted in our urological service as a
significant advance.
The origin of glomerular crescents in nephrotoxic serum nephri-
tis in the rabbit. Victoria Cattell and S. W. Jamieson. Depart-
ment of Pathology, St. Mary's Hospital Medical School, and
Cardiothoracic Unit, Brompton Hospital, London, England.
Methods similar to those in a study on the origin of mesangial
cells in proliferative glomerulonephntis have been used to inves-
tigate the origin of crescents and endocapillary hypercellularity
in nephrotoxic serum nephritis. Glomerulonephritis was induced
by an iv. injection of sheep antirabbit nephrotoxic serum (NTS),
0.5 mg/kg of body wt. Local glomerular proliferation was as-
sessed by mitotic counting and autoradiography 1 hr after a pulse
of tritiated thymidine (3H-T), 0.5 mCi/kg. Severe endocapillary
hypercellularity developed 4 to 6 days after NTS. During
this period there was little increase in local proliferation. Cres-
cent formation occurred between days 10 and 13. From day 8,
there was considerable local proliferation of glomerular epithelial
cells. To assess the role of infiltrating bone marrow cells, renal
transplantation in rabbits was developed. On either day 4 or day
9 after NTS, kidneys from unlabeled rabbits were transplanted
into prelabelled recipients (3H-T, 0.5 mCi/kg, i.v., every 12 hr for
3 days prior to transplantation) which had also received iv. NTS
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on the same day as donors. Glomerulonephritis developed in
transplants as in nontransplanted kidneys. Autoradiography of
biopsied transplants showed an influx of labeled cells in hyper-
cellular glomeruli on day 5 in kidneys transplanted on day
4. In constrast, in kidneys transplanted on day 9, few labeled
cells were found in crescents on day 10. We conclude that early
phase diffuse hypercellularity is largely due to monocyte infil-
tration and that crescents are principally formed by glomerular
epithelial cell proliferation.
The potential toxicity of phenols in uremia. D. Cook, Graham
Turner, and E. N. Wardle. Departments of Clinical Biochemistry
and Medicine, Royal Victoria Infirmary, Newcastle upon Tyne,
England. The same spectrum of toxicity has been claimed for
'middle molecules" as for lower mol wt substances such as
methylguanidine, the phenok, and the amines. Since phenols are
protein-bound and moreover lipid soluble, their dialysance is
limited, and there is a rebound of plasma levels to 80% within 5
hours of cessation of dialysis. The body has to cope with a load
of 300mg of phenolic compounds each day. They are found in all
vegetables, tea, and coffee, and are produced by the gut flora.
Review of the literature shows that the acidic phenolic acids and
the benzoic acids are inadequately detoxicated. They could ac-
count for neurological disturbance and anemia. Indeed, in exper-
iments with a human reticulocyte preparation, phenolic acids are
demonstrated to be powerful inhibitors of the A.L.A. dehydrase
that lies on the pathway of porphyrin synthesis and thus of haem
formation. Studies with phenols, phenolic acids, and even phe-
nyl-glucuronide (which although water-soluble will accumulate
in anuria) show biphasic effects on enzymes such as sodium-po-
tassium ATPase and brain adenyl cyclase, which suggest per-
turbation of the phospholipid environment, since there is stimu-
lation at low concentrations but inhibition at high concentra-
tions. Phenols are relevant to uremic coma and even more so to
hepatic coma.
Analgesic nephropathy in Nottingham. J. R. Cove-Smith and
M. S. Knapp. City Hospital, Nottingham, England. In 1970, it
was estimated that 450 to 500 new cases of analgesic nephropa-
thy would arise annually in England and Wales, but reported se-
ries suggest a lower incidence. A case-note survey of patients
with renal disease and an examination of 20,229 autopsy reports
were carried out to establish the prevalence of analgesic ne-
phropathy in Nottingham. Between 1970 and 1975, 55 patients
were seen. One third had previously been misdiagnosed (many
as "chronic pyelonephritis"), and analgesic abuse was only re-
vealed after careful questioning of patients and relatives. Analge-
sic nephropathy accounted for 12% of cases of chronic renal fail-
ure. Eight new cases were seen annually in a population of three-
quarter million, equivalent to 490 per year in England and Wales.
The calculated survival rate of the group was 44% at 5 years.
Mortality was related to the total estimated analgesic consump-
tion and the degree of renal failure at presentation. There was no
significant correlation between deterioration in renal function
and bacteriuria or hypertension. Forty-two percent of the pa-
tients had arthritis; most of these had been taking large quantities
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of phenacetin-containing analgesics. Renal papillary necrosis
was detected in only 26% radiologically, but was present in all
the patients examined at autopsy. Despite increasing awareness
of the dangers of analgesic abuse, analgesic nephropathy is still
underdiagnosed. If the diagnosis is delayed until the serum
creatinine concentration has risen above 400/molesIliter, 50%
will be dead within 3 years. A thorough history of analgesic con-
sumption and screening of the urine for metabolites of analgesic
mixtures should be undertaken in every patient presenting with
renal disease.
Association of hyperprolactinemia and renal disease in man. E.
A. Cowden, W. A. Ratcl,ffe, J. G. Ratcliffe, J. W. Dobbie, and
A. C. Kennedy. Radioimmunoassay Unit, Department of Bio-
chemistry and Tenovus Kidney Diseases Research Unit, Royal
Infirmary, Glasgiow, Scotland. It is established that prolactin is
an osmoregulatory hormone in many lower species, and it has
been reported that this hormone may be an etiological factor in
the chronic nephropathy of rats. The relationship between pro-
lactin and the kidney in man, however, is speculative. In a sur-
vey of 357 patients with renal disease, hyperprolactinemia, not
attributable to drugs, existed exclusively in patients with im-
paired renal function, 58% of all patients with renal failure having
elevated prolactin levels (> 360 mU/liter). Hyperprolactinemia
arising from altered renal metabolism was suggested by a signifi-
cant correlation of prolactin with creatinine levels concentra-
tions (r = 0.45; P < 0.005), the reversion of prolactin levels to-
wards normal after successful transplantation, and the demon-
stration of a consistent arteriovenous difference in prolactin
levels across the normal kidney (mean fall, 16%; range, 8—29%).
In addition, hypothalamic-pituitary control of prolactin secretion
has been studied in six hyperprolactinemic patients on mainte-
nance hemodialysis (3 males, 3 females; mean age, 33.2 yr;
range, 16—52 yr). Consistently, subnormal prolactin responses
both to TRH and maxolan stimulation and to i-dopa and bromo-
criptine suppression were demonstrated, suggesting that de-
ranged hypothalamic pituitary control may also contribute to the
elevated prolactin levels in renal failure.
Does hypergastrinemia cause peptic ulceration in patients with
chronic renal failure? C. C. Doherty. Renal Unit, Belfast City
Hospital, Ireland. It has been suggested that the frequent occur-
rence of peptic ulceration in renal dialysis patients may be due to
hypersecretion of acid because of elevated concentrations of cir-
culating gastrin. To examine this possibility, measurements of
plasma gastrin concentrations and gastric acid secretions were
carried out in 20 patients undergoing hemodialysis, 20 renal
transplant patients, and 20 healthy controls. These groups were
age- and sex-matched. The mean peak acid output was 27.2
mmoles/hr in controls and was significantly elevated in the dial-
ysis patients (35.9 mmoles/hr; P < 0.05) but not in renal trans-
plant patients with a functioning kidney for longer than one year
(24.2 mmoles/hr; P <0.25). Using a sensitive and specific radio-
immunoassay, we found that fasting plasma gastrin concentra-
tions were 36 (saM) 6 ng/liter in controls, 618 349 mg/liter in
the dialysis group (P < 0.0005), and 61 8 ng/liter in the trans-
plant group (P <0.025). In keeping with other studies, there was
no correlation between basal or peak acid output and gastnn con-
centrations. Following transplantation and the return of plasma
gastrin to within normal limits, however, the acid hypersecretion
noted in the dialysis phase was no longer apparent in patients
studied at least 1 yr after operation. This suggests that hyper-
gastrinemia is implicated in the hypersecretory state of dialysis
patients and, therefore, in the causation of peptic ulcers in these
subjects. The study also indicates that the likely mechanism of
this phenomenon is not the influence of gastrin on acid secretion
rates, but that it is a trophic effect on the gastric mucosa.
Distal renal tubular acidosis, factors determining systemic aci-
dosis with special reference to ammonia excretion. T. G. Feest and
0. M. Wrong. Departments of Medicine, Royal Victoria In-
firmary, Newcastle upon Tyne and University College Hospital,
London, England. Of the 70 patients with primary distal renal
tubular acidosis (DRTA) that we have studied, 22 did not have
systemic acidosis at the time of diagnosis as judged by plasma
total carbon dioxide concentration (Tco2). These patients differed
from those with acidosis in that very few were familial, none had
osteomalacia compared with 18 of the acidotic patients (P =
0.0004), and only 6 had hypokalaemia compared with 31 (P =
0.004). The factors which determine acidosis in DRTA have not
been compared. We have analyzed in our patients the inter-
relationships between plasma Tco2 in "normal" conditions and
minimum urine pH, stimulated urinary ammonia excretion rate
during six hours following an oral dose of ammonium chloride
0.1 g/kg, and creatinine clearance. There is a strong negative cor-
relation of plasma Tco2 with minimum urine pH (P < 0.0001),
and a positive correlation with stimulated ammonia excretion (P
= 0.0001) and creatinine clearance (P = 0.002). Stimulated am-
monia excretion correlates with creatinine clearance (P = 0.004)
and weakly negatively with minimum urine pH (P = 0.04). Anal-
ysis of partial correlation coefficients shows that minimum urine
pH and ability to excrete ammonia are the two factors which
determine systemic acidosis, the influence of creatinine clear-
ance being entirely mediated through its effect on ammonia ex-
cretion. The stimulated ammonia excretion rates of our DRTA
patients at any given clearance were similar to those of a group of
normal volunteers and patients with glomerulonephritis although
with a wider scatter, despite the fact that they suffered more se-
vere chronic acidosis which should increase urinary ammonia
excretion. Thus, there seems to be a defect of ammonia excre-
tion in many patients with DRTA which is out of proportion to
loss of creatinine clearance, although a few patients avoid acido-
sis by retaining a high urinary ammonia excretion rate.
Potential danger of parental iron therapy in hemodialysis pa-
tients. R. Gokal, P. R. Millard, S. T. E. Callender, D. 0. Oliver,
D. J. Weatherall, andJ. G. G. Ledingham. Nuffield Department
of Clinical Medicine, University of Oxford, Renal Unit, Church-
ill Hospital, Oxford, England. Because of doubts about adequate
intestinal iron absorption, some dialysis units replace iron losses
in patients undergoing maintenance hemodialysis treatment
(MHDT) with parental iron. Recent experiences in Oxford in-
dicate that this can lead to potentially dangerous iron-loading.
Sixty-one of 124 MHDT patients had serum ferritin concentra-
tions in excess of 1,000 /g/liter, and there was a good correla-
tion between these levels and the number of years on dialysis (r
= 0.7; P < 0.001). A retrospective postmortem study of 23
MHDT patients showed significant amounts of iron in liver and
spleen, and in 5 cases there was myocardial iron-loading. A simi-
lar analysis in 14 chronic renal failure patients, who had never
had MHDT, showed no iron-loading. Using 59Fe and the total
body counter, we found the iron absorption to be similar in both
MHDT patients with iron deficiency (mean saM; 42.5% 5.8)
and in iron deficient subjects without renal disease (45.3%
1.86). In iron replete MHDT patients, iron absorption (8.1%
2.6) did not differ significantly from normal controls (14.9%
1.6); however, it was significantly reduced in iron-loaded MHDT
patients (5.4% 0.7; P <0.005). There was an excellent correla-
tion between red cells indices (mean corpuscular hemoglobin and
mean corpuscular volume) and the iron stores (as judged by
serum ferritin concentrations) in MHDT patients. These find-
ings indicate that the control mechanisms which relate iron ab-
sorption to body iron stores are intact in patients on MHDT.
Hence, oral iron therapy is recommended, and it can be mon-
itored using red cell indices. Prolonged parenteral iron treatment
is unnecessary and potentially dangerous.
Autoimmune amplification of immunologically induced renal
tubulointerstitial disease in the guinea pig. C. L. Hall, R. B. Col-
yin, and R. T. McCluskey. Department of Renal Medicine,
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Queen Elizabeth Hospital, University of Birmingham, England,
and Department of Immunopathology, Massachusetts General
Hospital, Boston, Massachusetts. In contrast to renal glomeru-
lar disease, the immunopathologic mechanisms responsible for
renal tubular and interstitial diseases are poorly understood.
However, there is evidence that the deposition of both specific
antibodies to tubular basement membrane (TBM) antigens and
immune complexes may produce tubulointerstitial disease (TID).
To investigate the pathogenesis of autoimmune TID, a high titre
anti-TBM antiserum was raised in strain XIII guinea pigs by im-
munization with purified rabbit TBM in CFA. The antiserum was
fractionated by DEAE 52 column chromatography into function-
ally pure IgG1 and lgG2 isotypes. Autoimmune TID was induced
in isogeneic strain XIII guinea pigs by the passive transfer of the
LgG1 or lgG2 anti-TBM preparations. The IgG2 isotype appeared
more effective than the lgG1, but the immunopathologic features
of TID in the recipients were very similar at the time of sacrifice
on day 14 and appeared to be independent of complement fixa-
tion. The recipients that developed disease had higher than ex-
pected anti-TBM titres at day 14, which were found to be of both
Ig isotypes. In contrast, simultaneously administered IgG1 or
IgG2 anti-BGG antibodies declined in titre in the recipients and
were never found in the isotype fraction other than the one trans-
ferred. These findings indicate that the recipients of anti-TBM
antibodies of either lgG1 or IgG2 isotype were stimulated to pro-
duce anti-TBM autoantibodies of both isotypes which partici-
pated in the pathogenesis of the renal disease. Thus, the model
demonstrated that auto-antibody production may provide a
mechanism (autoimmune amplification) for the intensification
and perpetuation of antibody-mediated autoimmune disease. The
data are discussed further in relation to 1) the possibile mecha-
nisms of loss of tolerance to TBM antigens, 2) the rare occur-
rence of antibody-mediated TID in man, and 3) the possible ther-
apeutic role of measures which remove autoantibodies, such as
plasmaphoresis.
Is steroid responsive nephrotic syndrome (SRNS) an immune
complex disease? R. J. Levinsky, T. M. Barratt, P. M. Malleson,
andf. F. Soot hill, Department of Immunology, Institute of Child
Health, and Hospital for Sick Children, London, England. Sera
from all of 18 children (aged Ito 15 yr) who were in relapse with
steroid-responsive nephrotic syndrome contained raised levels
of soluble IgG containing antigen-antibody complexes, as mea-
sured by the inhibition of agglutination of IgG latex by rabbit 1gM
antihuman IgG reagent, whether or not the children were receiv-
ing steroids. Complex levels remained high up to 6 weeks after
cessation of proteinuria but fell to normal in sustained remission.
Complexes were not found in the serum of one child with con-
genital nephrotic syndrome. The complexes in the sera from four
children in relapse were of two sizes, with mol wt peaks of 3 to 5
x l0 and 2 to 2.5 x 106 daltons. The sera of the five children
studied, all of which contained such IgG complexes, did not in-
hibit Clq agglutination of IgG coated latex particles, suggesting
that these complexes did not bind Clq. These unusual complexes
may be involved in the presumed immunopathogenesis of this
disease or may be epiphenomenon of the provoking agent.
The emergence of thymine-requiring mutant bacteria during co-
trimoxazole therapy: An increasing phenomenon? Rosalind Mas-
kell, 0. A. Okubadejo, R. H. Payne, and Linda Pead. Public
Health Laboratory, St. Mary's General Hospital, Portsmouth,
and L. K. B. Instruments Ltd., South Croydon, Surrey, England.
Co-trimoxazole has been used for the treatment of urinary infec-
tions in this country since 1968; it is effective both for short-term
therapy and for long-term prophylaxis and suppression. In 1973,
however, there were reports of the isolation of thymine-requiring
mutant bacteria during co-trimoxazole treatment. From 1971 un-
til early 1975, we isolated these mutants from the urine of 8 pa-
tients, all of whom had renal calculi and associated urinary infec-
tion. All except one had been on co-trimoxazole therapy for sev-
eral months. We detected levels of thymine in the urine sufficient
to support their growth. Since 1975, however, we have been iso-
lating these organisms more frequently, now at the rate of ap-
proximately two a month, from some patients who have had only
short courses of treatment and from specimens other than urine.
They seem to emerge and survive in conditions of chronic sepsis,
and evidence is accumulating that they are pathogenic. Two of
our patients have had mutant septicemia from which one of them
died. We suggest a possible mechanism for the emergence of
these mutants; the fact that we are isolating them more frequent-
ly may have implications for the future use of co-trimoxazole in
these clinical situations.
A radiolabeled rheumatoid factor binding assay for the mea-
surement of circulating immune complexes. P. Naish and Joan
Barratt. Medical Research Laboratories, North Staffs, Medical
Centre, Stoke-on-Trent, England. An assay for circulating im-
mune complexes has been developed which involves the use of
radiolabeled, partially purified, monoclonal rhematoid factor and
the precipitation of this when combined with immune complexes
with 3% polyethylene glycol. The assay will detect approximate-
ly 0.35/g/ml of aggregated IgG. It has been shown that the assay
detects immune complexes formed both in vitro and in vivo
across a molecular size range of approximately 300,000 to 4.106
daltons, and will detect circulating immune complexes during the
course of acute BSA-induced serum sickness in the rabbit. Dur-
ing the recovery phase of this latter disease, a low mol wt react-
ant appeared in the serum which was almost certainly free anti-
BSA antibody. Human diseases in which circulating complexes
have been most frequently demonstrated include systemic lupus
erythematosus (SLE), poststreptococcal nephritis, infective
endocarditis-associated nephritis, idiopathic proliferative gb-
merulonephritis, and cutaneous and systemic vasculitis.
Changes in levels of circulating complexes parallel clinical evi-
dence of disease activity in SLE, poststreptococcal nephritis,
and in some cases of vasculitis. The results will be discussed in
relation to disease groups and activity, the serum complement,
and reactants other than immune complexes in the serum.
A strong association between antibodies to gbomerular basement
membrane (anti-GBM antibodies) and the major histocompatibi-
lity complex. A. J. Rees, D. A. S. Compston, J. R. Batchelor,
and D. K. Peters. Department of Medicine, Royal Postgraduate
Medical School, Hammersmith Hospital, Ducane Road, Lon-
don, and Mclndoe Memorial Research Unit, Queen Victoria
Hospital, East Grinstead, Surrey, England. We wish to report a
strong association between anti-GBM antibodies and the major
histocompatibility complex. Using well-validated antisera to A,
B, CW, and DRW loci, we have HLA-typed 20 Caucasian pa-
tients with nephritis caused by anti-GBM antibodies. Diagnosis
was established by characteristic renal immunofluorescence (18/
18) and demonstration of circulating anti-GBM antibody by ra-
dioimmunoassay (20/20). Definite HLA types at A, B, and CW
loci were assigned to all 20 patients, but poor viability of cells
complicated typing of the DRW locus, which is largely restricted
to B lymphocytes; definite DRW types were assigned to 17 pa-
tients and provisional types to a further two. The frequency of
HLA DRW2 was greatly increased: it was present in 15/17 (88%)
patients compared with 32/100 (32%) of local blood donor con-
trols, a difference which is highly significant even after correc-
tion for the number of antigens tested (P = 0.0004, Fisher's Ex-
act Test). In addition both patients with provisional types ap-
peared to possess DRW2. Although no significant differences in
antigen frequencies at A, B, and C loci were found, A3 (7/20
compared to 61/200) and B7 (10/20 compared to 62/200) were
both increased. This is to be expected because these antigens are
known to be in linkage disequilibrium with DRW2. Both patients
without DRW2 had typical anti-GBM disease and could not be
segregated from the remainder by clinical or other laboratory cri-
teria. Thus, it seems likely that there is a renal association of
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biological significance between HLA-DRW2 and the ability to
form anti-GBM antibodies. If so, it will be the first strong associ-
ation between the HLA complex and a disease whose immuno-
pathogenesis has been precisely defined. This finding has impor-
tant theoretical and practical implications which will be dis-
cussed.
Alternative pathway of complement defect in children with re-
current hematuria syndrome. A. Sirin, T. M. Barratt, B. A. M.
Harvey, J. F. Mowbray, and J. F. Sooth ill. Department of Im-
munology, Institute of Child Health, London, England. Recur-
rent hematuna syndrome (Berger's disease) is associated with
deposition of IgA and C3 in the kidney, presumably as antigen-
antibody complexes. Though IgA fails to activate the classic
pathway of complement, it can achieve immune elimination of
antigen, presumably by the alternative pathway. If the deposi-
tion of IgA in the kidney in these patients results from abnormal
persistence of circulating IgA complexes, this could be due to a
defect of the alternative pathway of complement. Hemolytic
complement was fixed less well by inulin and by E. coli endo-
toxin (alternative pathway activations) in the sera of 18 children
with this syndrome than it was in sera from health adults, from 10
children with genitourinary disease, and from 23 children with
miscellaneous glomerular diseases. Hemolytic complement, C3,
and immunoglobulin concentrations were normal, except that
three children had raised serum IgA, most were high in the nor-
mal range, and one was IgA-deficient. Unlike patients with an-
other defect of the alternative pathway of complement who pres-
ent with infections, allergy, and diarrhea, the sera from these
patients opsonized yeasts for polymorphonuclear phagocytosis
normally. Sera from 26 of their symptomless parents were simi-
larly defective, confirming that the defect was primary and sug-
gesting autosornal recessive inheritance. Sera from adults with
recurrent hematuria syndrome and renal IgA deposits showed
normal alternative pathway of complement activation. They
sometimes develop chronic renal failure, whereas children with
this syndrome rarely do. Our findings suggest that these two are
different diseases.
Critical role of urine acidificationin the enhanced ammoniagen.
esis of acute acidosis. R. L. Tannen and B. D. Ross. Nuffield De-
partment of Clinical Biochemistry, Radcliffe Infirmary, Oxford,
England. The metabolic response of the kidney to chronic acid-
osis includes an increase in ammonium production and in the rate
of gluconeogenesis. Acute acidosis on the other hand results in a
large increase in ammonia excretion, while in vitro preparations
of rat kidney show no increase in total ammonia production
when incubated at acid pH. In isolated rat kidney perfusions, it
has been possible to produce significant urine acidification (mean
urine pH, 5.85; range, 5.15 to 6.35, N = 23) by reducing the pH
and bicarbonate content of the perfusate from 7.4 and 23 m to
7.0 and 9.0 m, respectively. In control kidneys perfused at nor-
mal bicarbonate concentrations and physiological concentra-
tions of glutamine (0.5 mM) and glucose (5 mM), ammonia pro-
duction fell slightly with time. However, when acute acidosis
was produced after a control period of 30 to 45 mm, a significant
increase in ammonia production occurred during the subsequent
45 mm of perfusion (control, 1.35/.tmoles/min/g; acidosis, 1.71/
moles/min/g; N = 23). The increase in ammonia production in
individual perfusions was strongly correlated (r = 0.8) with the
minimum urine pH achieved. In those kidneys reaching a urine
pH of 6.0 or below, ammonium production increased from 1.26
0.10 to 1.9 0.21 (N = 12) (P <0.01). In the nonfiltering kidney
(perfused at low pressure and increased oncotic perfusion pres-
sure) acute acidosis produced only a small stimulation of am-
monia production (control, 1.01 0.O9vs. 1.23 0.14(N = 9)(P
<0.05). Increased ammoniagenesis occurs in acute acidosis and
depends upon the trapping ammonium in the urine. This in part
explains the inability to demonstrate the effect in fragmented in
vitro preparations, such as the kidney cortex slice and isolated
mitochondria.
Interaction of anti-GBM antibody and immune complexes in
rabbits. P. Trevillian and J. S. Cameron. Renal Unit, Depart-
ment of Medicine, Guy's Hospital, London, England. Anti-GBM
antibody is known to increase the glomerular uptake of carbon
particles and heat-aggregated lgG. An experiment was designed
to examine possible synergistic effects of administered anti-GBM
antibody and the presence of circulating immune complexes in
rabbits. A moderate dose of bovine serum albumin (BSA, 150
mg/kg, i.v.) did not cause overt nephritis in a control group of
New Zealand white rabbits, although in the majority of animals
there was proven immune elimination of the antigen with scanty
glomerular deposits. A small dose (3 mg/kg, iv.) of a nephrotox-
ic globulin (NTG) containing sheep antibodies to rabbit GBM did
not induce proteinuria when given to control animals. This dose
was given to three groups of test animals on day 5, day 7, or day
9 following injection of 150 mg BSA/kg, and the animals were
killed on day 15. In all animals receiving NTG on day 5, moder-
ate to severe nephritis occurred from around day 10 onwards.
Less severe, but more immediate nephritis was seen in those re-
ceiving NTG on day 9. However, only one rabbit injected with
NTG on day 7 developed a late nephritis. (One animal in this
latter group died at day 10 with severe pulmonary hemorrhage.)
All three groups showed greatly increased amounts of non-linear
immunofluorescent deposits in glomeruli when compared with
the control BSA animals. The deposits were distributed periph-
erally, adjacent to the GBM. Conclusions. 1) There is a marked
synergistic effect between two forms of immune glomerular dam-
age, that is, that mediated by anti-GBM antibody and immune
complexes. 2) Glomerular uptake of BSA complexes is increased
in the presence of anti-GBM antibody. 3)The timing of the inter-
action appears to be critical, with the most severe effects seen
when immune elimination coincides with active antibody fixation
in the glomeruli.
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Effect of levamisole on cutaneous responses to DNCB in chroni-
cally dialyzed patients. D. Bar-Sagi, Y. Maor, D. Modai. Assaf-
Harofeh Hospital, Zerifin, Israel. Twenty uremic patients or.
chronic hemodialysis were assessed with regard to the cutaneous
hypersensitivity reaction to DNCB. The same test was repeated
following three daily 150-mg doses of levamisole. Fourteen
healthy subjects served as controls. The local inflammatory re-
sponse I week after the sensitizing dose of 2,000 g of DNCB
was positive in 35% of the uremic group as compared to 100% of
the normal controls. Delayed cutaneous response to a challenge
dose of 100 sg of DNCB was positive according to accepted cri-
teria in three of the uremic group (15%), compared to 12 positive
reactions in the control group (86%). One additional uremic sub-
ject exhibited a response which was positive in extent but was
delayed by 10 days. Three more uremic patients had a response
which was both diminished and abnormally delayed. When Le-
vamisole was administered simultaneously with a repeated chal-
lenge of DNCB, three uremic patients (15%) showed reinforce-
